Literature DB >> 30450319

New insight into the role of the complement in the most common types of retinopathy-current literature review.

Martyna Chrzanowska1, Anna Modrzejewska1, Monika Modrzejewska1.   

Abstract

Pathological neovascularisation, which is a critical component of diseases such as age-related macular degeneration (AMD), diabetic retinopathy (DR) and retinopathy of prematurity (ROP), is a frequent cause of compromised vision or blindness. Researchers continuously investigate the role of the complement system in the pathogenesis of retinopathy. Studies have confirmed the role of factors H and I in the development of AMD, and factors H and B in the development of DR. Other components, such as C2, C3, and C5, have also been considered. However, findings on the involvement of the complement system in the pathogenesis of ROP are still inconclusive. This paper presents a review of the current literature data, pointing to the novel results and achievements from research into the role of complement components in the development of retinopathy. There is still a need to continue research in new directions, and to gather more detailed information about this problem which will be useful in the treatment of these diseases.

Entities:  

Keywords:  age-related macular degeneration; diabetic retinopathy; factors of the complement system; retinopathy of prematurity; single nucleotide polymorphism

Year:  2018        PMID: 30450319      PMCID: PMC6232322          DOI: 10.18240/ijo.2018.11.19

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  88 in total

1.  A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration.

Authors:  Hannes Helgason; Patrick Sulem; Maheswara R Duvvari; Hongrong Luo; Gudmar Thorleifsson; Hreinn Stefansson; Ingileif Jonsdottir; Gisli Masson; Daniel F Gudbjartsson; G Bragi Walters; Olafur Th Magnusson; Augustine Kong; Thorunn Rafnar; Lambertus A Kiemeney; Frederieke E Schoenmaker-Koller; Ling Zhao; Camiel J F Boon; Yaojun Song; Sascha Fauser; Michelle Pei; Tina Ristau; Shirrina Patel; Sandra Liakopoulos; Johannes P H van de Ven; Carel B Hoyng; Henry Ferreyra; Yaou Duan; Paul S Bernstein; Asbjorg Geirsdottir; Gudleif Helgadottir; Einar Stefansson; Anneke I den Hollander; Kang Zhang; Fridbert Jonasson; Haraldur Sigurdsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2013-09-15       Impact factor: 38.330

2.  Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant.

Authors:  Nadine Lauer; Michael Mihlan; Andrea Hartmann; Ursula Schlötzer-Schrehardt; Claudia Keilhauer; Hendrik P N Scholl; Peter Charbel Issa; Frank Holz; Bernhard H F Weber; Christine Skerka; Peter F Zipfel
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

3.  Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry.

Authors:  Hao Wang; Le Feng; Jianwen Hu; Chunlei Xie; Fang Wang
Journal:  Exp Eye Res       Date:  2012-12-28       Impact factor: 3.467

4.  Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.

Authors:  Verena B Gerl; Jürgen Bohl; Susanne Pitz; Bernhard Stoffelns; Norbert Pfeiffer; Sucharit Bhakdi
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

5.  Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.

Authors:  Sarah Ennis; Catherine Jomary; Robert Mullins; Angela Cree; Xiaoli Chen; Alex Macleod; Stephen Jones; Andrew Collins; Edwin Stone; Andrew Lotery
Journal:  Lancet       Date:  2008-10-06       Impact factor: 79.321

Review 6.  Complement Activation and Inhibition in Retinal Diseases.

Authors:  Mark E Kleinman; Jayakrishna Ambati
Journal:  Dev Ophthalmol       Date:  2015-10-26

7.  His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form.

Authors:  Simon J Clark; Victoria A Higman; Barbara Mulloy; Stephen J Perkins; Susan M Lea; Robert B Sim; Anthony J Day
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

8.  Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid.

Authors:  Chang Luo; Mei Chen; Heping Xu
Journal:  Mol Vis       Date:  2011-06-14       Impact factor: 2.367

9.  Genetic Investigation of Complement Pathway Genes in Type 2 Diabetic Retinopathy: An Inflammatory Perspective.

Authors:  Ming Ming Yang; Jun Wang; Hong Ren; Yun Duan Sun; Jiao Jie Fan; Yan Teng; Yan Bo Li
Journal:  Mediators Inflamm       Date:  2016-02-16       Impact factor: 4.711

10.  Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: Complement activation in AMD.

Authors:  Judith Lechner; Mei Chen; Ruth E Hogg; Levente Toth; Giuliana Silvestri; Usha Chakravarthy; Heping Xu
Journal:  Immun Ageing       Date:  2016-02-16       Impact factor: 6.400

View more
  3 in total

Review 1.  Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.

Authors:  Alicia J Jenkins; Maria B Grant; Julia V Busik
Journal:  Diabetologia       Date:  2022-02-11       Impact factor: 10.460

2.  Exposure to Porphyromonas gingivalis and Modifiable Risk Factors Modulate Risk for Early Diabetic Retinopathy.

Authors:  Chung-Jung Chiu; Min-Lee Chang; Alpdogan Kantarci; Thomas E Van Dyke; Wenyuan Shi
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.283

3.  Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy.

Authors:  Nikhil Mandava; Vanessa Tirado-Gonzalez; Matthew D Geiger; Jennifer L Patnaik; Ashley Frazer-Abel; Anne M Lynch; Naresh Mandava; Alan G Palestine; V Michael Holers; Brandie D Wagner; Idaira Sanchez-Santos; Daniela Meizner; Hugo Quiroz-Mercado; Jesse M Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.